Financhill
Sell
18

RHHVF Quote, Financials, Valuation and Earnings

Last price:
$317.83
Seasonality move :
1.99%
Day range:
$315.24 - $325.11
52-week range:
$269.80 - $354.19
Dividend yield:
3.47%
P/E ratio:
28.74x
P/S ratio:
3.62x
P/B ratio:
7.15x
Volume:
1.1K
Avg. volume:
7.1K
1-year change:
10.01%
Market cap:
$251.3B
Revenue:
$70.9B
EPS (TTM):
$11.48

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Roche Holding AG has -- downside to fair value with a price target of -- per share.

RHHVF vs. S&P 500

  • Over the past 5 trading days, Roche Holding AG has underperformed the S&P 500 by -0.18% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Roche Holding AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Roche Holding AG has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Roche Holding AG reported revenues of --.

Earnings Growth

  • Roche Holding AG has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Roche Holding AG reported earnings per share of --.
Enterprise value:
275.3B
EV / Invested capital:
--
Price / LTM sales:
3.62x
EV / EBIT:
18.69x
EV / Revenue:
3.93x
PEG ratio (5yr expected):
--
EV / Free cash flow:
16.21x
Price / Operating cash flow:
14.92x
Enterprise value / EBITDA:
14.82x
Gross Profit (TTM):
$51.7B
Return On Assets:
8.46%
Net Income Margin (TTM):
13.16%
Return On Equity:
23.8%
Return On Invested Capital:
12.15%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-07-16 2024-07-16 2024-07-16
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $37.7B $39B $36.5B $39.8B $44.3B
Total Assets $98.6B $101B $95.1B $107.7B $112.7B
Current Liabilities $29.1B $42B $29.4B $29.6B $29.9B
Total Liabilities $53.1B $70B $60.5B $68.1B $72.6B
Total Equity $45.5B $31B $34.5B $39.6B $40B
Total Debt $16.3B $34.1B $27.3B $34.8B $38.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-07-16 2024-07-16 2024-07-16
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
RHHVF
Sector
Market Cap
$251.3B
$34.5M
Price % of 52-Week High
89.2%
49.05%
Dividend Yield
3.47%
0%
Shareholder Yield
2.96%
-1.01%
1-Year Price Total Return
10.01%
-35.15%
Beta (5-Year)
0.472
0.615
Dividend yield:
3.47%
Annualized payout:
$10.93
Payout ratio:
91.76%
Growth streak:
3 years

Technicals

8-day SMA
Sell
Level $322.57
200-day SMA
Buy
Level $312.34
Bollinger Bands (100)
Sell
Level 310.09 - 338.19
Chaikin Money Flow
Sell
Level -709
20-day SMA
Sell
Level $322.21
Relative Strength Index (RSI14)
Sell
Level 44.63
ADX Line
Sell
Level 12.53
Williams %R
Buy
Level -96.1419
50-day SMA
Sell
Level $321.04
MACD (12, 26)
Buy
Level 84.65
25-day Aroon Oscillator
Sell
Level -24
On Balance Volume
Sell
Level -549

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.664)
Sell
CA Score (Annual)
Level (-0.4354)
Buy
Beneish M-Score (Annual)
Level (-3.0502)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.9676)
Buy
Piotroski F Score (Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Stock Forecast FAQ

In the current month, RHHVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The RHHVF average analyst price target in the past 3 months is --.

  • Where Will Roche Holding AG Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Roche Holding AG share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Roche Holding AG?

    Analysts are divided on their view about Roche Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Roche Holding AG is a Sell and believe this share price will rise from its current level to --.

  • What Is Roche Holding AG's Price Target?

    The price target for Roche Holding AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is RHHVF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Roche Holding AG is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of RHHVF?

    You can purchase shares of Roche Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Roche Holding AG shares.

  • What Is The Roche Holding AG Share Price Today?

    Roche Holding AG was last trading at $317.83 per share. This represents the most recent stock quote for Roche Holding AG. Yesterday, Roche Holding AG closed at $315.94 per share.

  • How To Buy Roche Holding AG Stock Online?

    In order to purchase Roche Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Can SharkNinja Stock Go?
How High Can SharkNinja Stock Go?

If you know popular consumer appliance brands Shark and Ninja,…

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
78
SBET alert for Jul 16

SharpLink Gaming [SBET] is up 28.58% over the past day.

Buy
75
MP alert for Jul 16

MP Materials [MP] is up 0.48% over the past day.

Sell
38
NAIL alert for Jul 16

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 2.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock